Allegro R - Search Results

1

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy.

Serretta V, Sommatino F, Gesolfo CS, Franco V, Cicero G, Allegro R. Serretta V, et al. Among authors: allegro r. Urol Ann. 2015 Jan-Mar;7(1):21-5. doi: 10.4103/0974-7796.148582. Urol Ann. 2015. PMID: 25657538 Free PMC article.

2

Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma.

Serretta V, Altieri V, Morgia G, Di Lallo A, Carrieri G, Allegro R; Gruppo Studi Tumori Urologici (GSTU) Foundation. Serretta V, et al. Among authors: allegro r. Urology. 2013 Feb;81(2):277-81. doi: 10.1016/j.urology.2012.09.040. Urology. 2013. PMID: 23374781

3

TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.

Serretta V, Pavone C, Ingargiola GB, Daricello G, Allegro R, Pavone-Macaluso M. Serretta V, et al. Among authors: allegro r. Eur Urol. 2004 Jun;45(6):730-5; discussion 735-6. doi: 10.1016/j.eururo.2003.12.002. Eur Urol. 2004. PMID: 15149744

4

Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions.

Serretta V, Galuffo A, Pavone C, Allegro R, Pavone-MacAluso M. Serretta V, et al. Among authors: allegro r. Urology. 2005 Jan;65(1):65-9. doi: 10.1016/j.urology.2004.08.027. Urology. 2005. PMID: 15667865 Clinical Trial.

5

Multiplicity and history have a detrimental effect on survival of patients with T1G3 bladder tumors selected for conservative treatment.

Serretta V, Ruggirello A, Dispensa N, Allegro R, Aragona F, Melloni D. Serretta V, et al. Among authors: allegro r. J Urol. 2008 Sep;180(3):886-90; discussion 891. doi: 10.1016/j.juro.2008.05.013. Epub 2008 Jul 17. J Urol. 2008. PMID: 18635223

6

A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer.

Serretta V, Morgia G, Altieri V, Di Lallo A, Ruggiero G, Salzano L, Battaglia M, Falsaperla M, Zito A, Sblendorio D, Melloni D, Allegro R; members of Gruppo Studi Tumori Urologici (GSTU) Foundation. Serretta V, et al. Among authors: allegro r. BJU Int. 2010 Jul;106(2):212-7. doi: 10.1111/j.1464-410X.2009.09153.x. Epub 2010 Jan 11. BJU Int. 2010. PMID: 20070299 Clinical Trial.

7

Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression.

Di Maida F, Mari A, Scalici Gesolfo C, Cangemi A, Allegro R, Sforza S, Cocci A, Tellini R, Masieri L, Russo A, Carini M, Minervini A, Serretta V. Di Maida F, et al. Among authors: allegro r. Clin Genitourin Cancer. 2019 Aug;17(4):e751-e758. doi: 10.1016/j.clgc.2019.04.008. Epub 2019 Apr 26. Clin Genitourin Cancer. 2019. PMID: 31126772

8

[Prevention of topic toxicity of BCG with single-dose prulifloxacin. Preliminary results of a randomized pilot study].

Serretta V, Ruggirello A, Giaimo R, Sommatino F, Billone V, Allegro R, Melloni D. Serretta V, et al. Among authors: allegro r. Urologia. 2010 Oct-Dec;77(4):240-7. Urologia. 2010. PMID: 21234866 Clinical Trial. Italian.

9

Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder. A study from Gruppo Studi Tumori Urologici Foundation.

Serretta V, Morgia G, Altieri V, Pavone-Macaluso M, Scuto F, Allegro R, Di Lallo A, Cindolo L, Melloni D; Gruppo Studi Tumori Urologici Foundation. Serretta V, et al. Among authors: allegro r. Urol Int. 2006;77(2):152-8. doi: 10.1159/000093911. Urol Int. 2006. PMID: 16888422

10

Correlation between GP-170 expression, prognosis, and chemoresistance of superficial bladder carcinoma.

Serretta V, Pavone C, Allegro R, Vella M, Sanguedolce R, Porcasi R, Morello V, Tomasino RM, Pavone-Macaluso M. Serretta V, et al. Among authors: allegro r. J Cancer Res Clin Oncol. 2003 Aug;129(8):472-6. doi: 10.1007/s00432-003-0455-5. Epub 2003 Jul 15. J Cancer Res Clin Oncol. 2003. PMID: 12884023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters